BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19589203)

  • 21. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
    Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
    J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas.
    Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
    Cancer Gene Ther; 2000 May; 7(5):732-8. PubMed ID: 10830720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
    Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
    Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically modified myeloma cell vaccine inducing antitumor immune response in vivo.
    Ren SP; Wang LS; Guo Q; Wang H; Jia XX; Xu J; Wang HX; Wu CT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):54-60. PubMed ID: 16584592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
    Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
    Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
    Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
    Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated transfer of p53 augments hyperthermia-induced apoptosis in U251 glioma cells.
    Okamoto K; Shinoura N; Egawa N; Asai A; Kirino T; Shibasaki F; Shitara N
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):525-31. PubMed ID: 11380242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines.
    Kim SK; Wang KC; Cho BK; Chung HT; Kim YY; Lim SY; Lee CT; Kim HJ
    J Neurosurg; 2002 Jul; 97(1):143-50. PubMed ID: 12134905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.
    Parney IF; Chang LJ; Farr-Jones MA; Hao C; Smylie M; Petruk KC
    J Neurooncol; 2006 May; 78(1):71-80. PubMed ID: 16718522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O; Síma P; Kunke D
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma.
    Arafat WO; Buchsbaum DJ; Gómez-Navarro J; Tawil SA; Olsen C; Xiang J; El-Akad H; Salama AM; Badib AO; Stackhouse MA; Curiel DT
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1037-50. PubMed ID: 12605984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells.
    Nashimoto T; Komata T; Kanzawa T; Aoki H; Endo S; Kon T; Uzuka T; Takahashi H; Kondo S; Tanaka R
    Int J Hyperthermia; 2005 Nov; 21(7):615-29. PubMed ID: 16278167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells.
    Lakatosová-Andelová M; Jinoch P; Dusková M; Marinov I; Vonka V
    Int J Oncol; 2008 Jan; 32(1):265-71. PubMed ID: 18097567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
    Shinoura N; Muramatsu Y; Nishimura M; Yoshida Y; Saito A; Yokoyama T; Furukawa T; Horii A; Hashimoto M; Asai A; Kirino T; Hamada H
    Cancer Res; 1999 Nov; 59(21):5521-8. PubMed ID: 10554029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
    Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.